| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 21, 2023 |
| Accession Number: | 0001193125-23-190511 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/13/2022 | $18.00 | Buy | Jefferies |
| 7/1/2022 | $23.00 | Overweight | Piper Sandler |
Jefferies initiated coverage of VectivBio with a rating of Buy and set a new price target of $18.00
Piper Sandler initiated coverage of VectivBio with a rating of Overweight and set a new price target of $23.00
SVB Leerink initiated coverage of VectivBio Holding with a rating of Outperform and set a new price target of $28.00